A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Aura Biosciences
Aura Biosciences
Bristol-Myers Squibb
Astellas Pharma Inc
EvolveImmune United, Inc
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
CG Oncology, Inc.
Bayer
Seagen Inc.
Pfizer
Pfizer
Pfizer
Nucleix Ltd.
Merck Sharp & Dohme LLC
IDEAYA Biosciences
Merck Sharp & Dohme LLC
Photocure
Aulos Bioscience, Inc.
AstraZeneca
AstraZeneca
Beijing Biotech
Eli Lilly and Company
Eli Lilly and Company
Verity Pharmaceuticals Inc.
Daiichi Sankyo
Eli Lilly and Company
Origin Sciences
BeOne Medicines
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Tasca Therapeutics
Pilatus Biosciences Inc
Clasp Therapeutics, Inc.
MacroGenics
Daiichi Sankyo
Protara Therapeutics
enGene, Inc.
Adela, Inc
Elephas
Seagen Inc.
Var2 Pharmaceuticals
Elephas
OncoNano Medicine, Inc.
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Photocure
Pacific Edge Limited
Massive Bio, Inc.
Guardant Health, Inc.
Daiichi Sankyo